51 participants
Extreme Bipolar Androgen Therapy With Darolutamide and Testosterone Cypionate in Patients With Metastatic Castration-Resistant Prostate Cancer (ExBAT Trial)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-28
- Start Date:
- 2021-06-09
- Completion:
- 2023-03-28
Conditions
- Prostate Cancer
Interventions
- DRUG
No Results Yet